Patent · US Active

EP2 receptor agonists

US7803841B2 · kind B2 · utility

6Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 2008
Grant dateSep 28, 2010
Priority date
Expiry dateDec 30, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure provides EP2 receptor agonist compounds and methods for using the compounds for treating conditions which can be alleviated by agonism of an EP2 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.